| Particulars |
| Company Name |
Zydus Lifesciences Ltd |
| Face Value |
1 |
| BSE Code |
532321 |
| Year End |
202303 |
| Full Year |
| Equity (Rs in Cr.) |
100.62 |
| B.V. Rs |
145.10 |
| Sales Rs in Cr. |
8,731.60 |
| NP Rs in Cr. |
1,621.61 |
| NP Var% |
48.00 |
| Div% |
600.00 |
| CPS Rs |
21.00 |
| EPS Rs |
16.10 |
| Traded Value(Rs in Lakhs) |
400.44 |
| 52 Week High |
1,031.00 |
| 52 Week Low |
483.00 |
| Price BSE |
954.00 |
| Price NSE |
954.00 |
| Market Capital(Rs in Cr.) |
95,954.47 |
| P/C Ratio |
45.50 |
| P/E Ratio |
59.20 |
| Price Vs.BV |
6.57 |
| Latest Quarter |
| Year End |
202312 |
| Sales Rs in Cr. |
2,225.10 |
| NP Rs in Cr. |
450.40 |
| NP Var % |
76.00 |
| Trailing Twelve Months |
| Year End |
202312 |
| Sales |
7,682.70 |
| OPM |
29.20 |
| NP |
1,226.50 |
| NP Var% |
109.11 |
| EPS |
26.71 |
| PE |
35.70 |
|